These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 15221373)

  • 1. TiA1 in advanced-stage classical Hodgkin's lymphoma: no prognostic impact for positive tumour cells or number of cytotoxic cells.
    Camilleri-Broët S; Fermé C; Berger F; Lepage E; Bain S; Brière J; Marmey B; Gaulard P; Audouin J
    Virchows Arch; 2004 Oct; 445(4):344-6. PubMed ID: 15221373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low p53 and high bcl-2 expression in Reed-Sternberg cells predicts poor clinical outcome for Hodgkin's disease: involvement of apoptosis resistance?
    Brink AA; Oudejans JJ; van den Brule AJ; Kluin PM; Horstman A; Ossenkoppele GJ; van Heerde P; Jiwa M; Meijer CJ
    Mod Pathol; 1998 Apr; 11(4):376-83. PubMed ID: 9578089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic molecule expression is predictive of prognosis in Hodgkin's-like anaplastic large cell lymphoma.
    Asano N; Suzuki R; Matsuo K; Kagami Y; Ishida F; Tamaru JI; Jin GS; Sato Y; Shimoyama Y; Yoshino T; Morishima Y; Nakamura S
    Histopathology; 2007 May; 50(6):705-15. PubMed ID: 17493234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of TIA1 and PAX5 in Classical Hodgkin Lymphoma at Initial Diagnosis May Predict Clinical Outcome.
    Nguyen TT; Frater JL; Klein J; Chen L; Bartlett NL; Foyil KV; Kreisel FH
    Appl Immunohistochem Mol Morphol; 2016 Jul; 24(6):383-91. PubMed ID: 26067141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression and significance of B-cell-specific activator protein of H/RS cell in classical Hodgkin's Lymphoma].
    Zhou X; Zhao T; Qi Z; Liu G; Zhu M
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1532-5. PubMed ID: 12609061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical expression of angiogenic cytokines in childhood Hodgkin lymphoma.
    Citak EC; Oguz A; Karadeniz C; Akyurek N
    Pathol Res Pract; 2008; 204(2):89-96. PubMed ID: 18207652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells.
    Alvaro T; Lejeune M; Salvadó MT; Bosch R; García JF; Jaén J; Banham AH; Roncador G; Montalbán C; Piris MA
    Clin Cancer Res; 2005 Feb; 11(4):1467-73. PubMed ID: 15746048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease.
    Doussis-Anagnostopoulou IA; Talks KL; Turley H; Debnam P; Tan DC; Mariatos G; Gorgoulis V; Kittas C; Gatter KC
    J Pathol; 2002 Aug; 197(5):677-83. PubMed ID: 12210089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease.
    Kanavaros P; Vlychou M; Stefanaki K; Rontogianni D; Gaulard P; Pantelidaki E; Zois M; Darivianaki K; Georgoulias V; Boulland ML; Gorgoulis V; Kittas C
    Anticancer Res; 1999; 19(2A):1209-16. PubMed ID: 10368677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease: associations with presenting features and clinical outcome.
    Rassidakis GZ; Medeiros LJ; Viviani S; Bonfante V; Nadali GP; Vassilakopoulos TP; Mesina O; Herling M; Angelopoulou MK; Giardini R; Chilosi M; Kittas C; McLaughlin P; Rodriguez MA; Romaguera J; Bonadonna G; Gianni AM; Pizzolo G; Pangalis GA; Cabanillas F; Sarris AH
    J Clin Oncol; 2002 Mar; 20(5):1278-87. PubMed ID: 11870170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-infiltrating cells as a prognostic factor in Hodgkin's lymphoma: a quantitative tissue microarray study in a large retrospective cohort of 267 patients.
    Alvaro-Naranjo T; Lejeune M; Salvadó-Usach MT; Bosch-Príncep R; Reverter-Branchat G; Jaén-Martínez J; Pons-Ferré LE
    Leuk Lymphoma; 2005 Nov; 46(11):1581-91. PubMed ID: 16236613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granzyme B expression in Reed-Sternberg cells of Hodgkin's disease.
    Oudejans JJ; Kummer JA; Jiwa M; van der Valk P; Ossenkoppele GJ; Kluin PM; Kluin-Nelemans JC; Meijer CJ
    Am J Pathol; 1996 Jan; 148(1):233-40. PubMed ID: 8546210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma.
    van den Berg A; Visser L; Poppema S
    Am J Pathol; 1999 Jun; 154(6):1685-91. PubMed ID: 10362793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXP3(+) regulatory and TIA-1(+) cytotoxic T lymphocytes in HIV-associated Hodgkin lymphoma.
    Kiyasu J; Aoki R; Tanaka PY; Pracchia LF; Calore EE; Perez NM; Kimura Y; Niino D; Sugita Y; Takayanagi R; Abe Y; Matsuoka M; Ohshima K
    Pathol Int; 2012 Feb; 62(2):77-83. PubMed ID: 22243776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mummified Hodgkin and Reed-Sternberg cells in EBV positive and EBV negative Hodgkin's lymphomas, Bcl-2 positivity and evaluation of survival].
    Macák J; Bertová M
    Vnitr Lek; 2001 Mar; 47(3):151-5. PubMed ID: 15635876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour-associated mast cells in classical Hodgkin's lymphoma: correlation with histological subtype, other tumour-infiltrating inflammatory cell subsets and outcome.
    Andersen MD; Kamper P; Nielsen PS; Bendix K; Riber-Hansen R; Steiniche T; Hamilton-Dutoit S; Clausen M; d'Amore F
    Eur J Haematol; 2016 Mar; 96(3):252-9. PubMed ID: 25963595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation?
    Pinkus GS; Pinkus JL; Langhoff E; Matsumura F; Yamashiro S; Mosialos G; Said JW
    Am J Pathol; 1997 Feb; 150(2):543-62. PubMed ID: 9033270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin's disease with or without histologic features of Castleman's disease.
    Hsu SM; Xie SS; Hsu PL; Waldron JA
    Am J Pathol; 1992 Jul; 141(1):129-38. PubMed ID: 1632458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Epstein-Barr virus in Hodgkin-Reed-Sternberg cells : no evidence for the persistence of integrated viral fragments inLatent membrane protein-1 (LMP-1)-negative classical Hodgkin's disease.
    Staratschek-Jox A; Kotkowski S; Belge G; Rüdiger T; Bullerdiek J; Diehl V; Wolf J
    Am J Pathol; 2000 Jan; 156(1):209-16. PubMed ID: 10623669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic impact of tumour-associated macrophages and Reed-Sternberg cells in paediatric Hodgkin lymphoma.
    Gupta S; Yeh S; Chami R; Punnett A; Chung C
    Eur J Cancer; 2013 Oct; 49(15):3255-61. PubMed ID: 23791542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.